Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

You may be eligible if

• All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
• All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
• All subjects must be able to comprehend and communicate in English.
• All subjects must agree to participate.
• A previous diagnosis of cancer is not an exclusion criterion.
• Previous genetic screening is not an exclusion criterion.
• Patients with a diagnosis of a low malignant potential mullerian tumor.
• Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.